Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma

NCT01239394

Conditions: Chronic Disease, Disease Attributes, Follicular Lymphoma, +21 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission

NCT00476047

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia

NCT01457040

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Department of Hematology, Nanfang Hospital Guangzhou, Guangdong, China

View Trial Details

Completed

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

NCT00301951

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +55 more
Locations: UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma

NCT01682044

Conditions: Chronic Disease, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, +51 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

NCT00659425

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Research Site Los Angeles, California, United States

Research Site Bethesda, Maryland, United States

Research Site Boston, Massachusetts, United States

Research Site Memphis, Tennessee, United States

View Trial Details

Completed

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

NCT00309907

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Children's Oncology Group Arcadia, California, United States

Loma Linda University Medical Center Loma Linda, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

View all 26 locations

View Trial Details

Completed

Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT02544438

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
Locations: Rambam medical center hematology department Haifa, Israel

Tel Aviv Sourasky Medical Center Tel Aviv, Israel

View Trial Details

Completed

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00245037

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Completed

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

NCT00238433

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +37 more
Locations: Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions